The estimated Net Worth of Jose H Bedoya is at least $1.47 Milione dollars as of 8 February 2024. Mr. Bedoya owns over 3,932 units of Surmodics stock worth over $1,181,137 and over the last 21 years he sold SRDX stock worth over $144,174. In addition, he makes $148,000 as Independent Director at Surmodics.
Jose has made over 10 trades of the Surmodics stock since 2013, according to the Form 4 filled with the SEC. Most recently he exercised 3,932 units of SRDX stock worth $94,171 on 8 February 2024.
The largest trade he's ever made was exercising 11,450 units of Surmodics stock on 21 May 2018 worth over $141,980. On average, Jose trades about 1,280 units every 88 days since 2004. As of 8 February 2024 he still owns at least 30,108 units of Surmodics stock.
You can see the complete history of Mr. Bedoya stock trades at the bottom of the page.
Jose H. Bedoya serves as Independent Director of the Company. He has been a director of the Company since 2002. Mr. Bedoya served as President and Chief Executive Officer of Otologics, LLC, a Colorado-based technology company he founded in 1996, until 2015. Otologics filed for Chapter 11 bankruptcy protection in July 2012. From 1986 to 1996, Mr. Bedoya held a number of positions at Storz Instrument Company, then a division of American Cyanamid and later a division of American Home Products, including Director of Operations, Director of Research and Director of Commercial Development. Prior to that, he served as Vice President of Research and Development for Bausch & Lomb’s surgical division.
As the Independent Director of Surmodics, the total compensation of Jose Bedoya at Surmodics is $148,000. There are 15 executives at Surmodics getting paid more, with Gary Maharaj having the highest compensation of $2,343,630.
Jose Bedoya is 63, he's been the Independent Director of Surmodics since 2002. There are 3 older and 17 younger executives at Surmodics. The oldest executive at Surmodics, Inc. is David Dantzker, 76, who is the Independent Director.
Jose's mailing address filed with the SEC is 604 10TH STREET, , BOULDER, CO, 80302.
Over the last 21 years, insiders at Surmodics have traded over $26,204,565 worth of Surmodics stock and bought 19,725 units worth $436,251 . The most active insiders traders include Jeffrey C Smith, Gary R Maharaj e Value Lp Starboard Value Gp.... On average, Surmodics executives and independent directors trade stock every 34 days with the average trade being worth of $415,014. The most recent stock trade was executed by Joseph J. Stich on 21 August 2024, trading 21,285 units of SRDX stock currently worth $706,662.
surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.
Surmodics executives and other stock owners filed with the SEC include: